Mahmoud D. Aljurf
Riyadh, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 477 publications
A Comprehensive Rehabilitation Framework to help optimize outcomes across the CAR-T Continuum - White Paper Report.
Journal: Transplantation and cellular therapy
Published: June 24, 2026
Search Prognosis Driven Transplantation: A New Paradigm for Donor Selection in Allogeneic HCT.
Journal: Transplantation and cellular therapy
Published: June 09, 2026
From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma.
Journal: Expert review of hematology
Published: May 27, 2026
Impact of mental health on outcomes of patients with relapsed and/or refractory diffuse large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
Journal: Hematology/oncology and stem cell therapy
Published: April 28, 2026
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group.
Journal: The Lancet. Haematology
Published: April 25, 2026
Blinatumomab and ponatinib with central nervous system treatment intensification for adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukemia.
Journal: Haematologica
Published: April 16, 2026
Treosulfan-Based Conditioning in Allogeneic Stem Cell Transplantation for Myelofibrosis: A Systematic Review.
Journal: Journal of clinical medicine
Published: April 10, 2026
Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis.
Journal: Transplantation and cellular therapy
Published: April 03, 2026
Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma.
Journal: Haematologica
Published: March 31, 2026
MRD-guided de-escalation of TBI conditioning in ALL.
Journal: Bone marrow transplantation
Published: March 30, 2026
Reduced-dose post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in matched donor allogeneic stem cell transplantation: a systematic review of efficacy and toxicity.
Journal: Transplantation and cellular therapy
Published: March 28, 2026
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
Journal: Bone marrow transplantation
Published: March 21, 2026
Last Updated: 09/26/2026